What is Troponin Diagnostic Tests Market Scope?
A troponin test is to measures the level of troponin in blood. A protein found in the muscles of your heart, which isn't normally found in the blood. Troponin is sent into the bloodstream when heart muscles become damaged. This test is most prominently used to diagnose a heart attack. Along with this also used to monitor angina, which limits blood flow to the heart and causes chest pain. It has been estimated that 840,000 Americans die of cardiovascular diseases each year. In 2017 Food and Drug Administration (FDA) approved since then many laboratories in the U.S. used high-sensitivity troponin tests.
The Troponin Diagnostic Tests market study is being classified by Type (Troponin I ELISA Test and Troponin Rapid test) and major geographies with country level break-up.
Major manufacturers of the products are well-established pharma companies and they are mainly focusing on the research and development of the products like up-gradation of testing kit 4th generation to 5th generation which is more accurate, can detect a fraction of fluctuations in troponin. Although the leading pharma companies focusing on more acquisitions of the small scale companies to reach out. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Troponin Diagnostic Tests market throughout the predicted period.
Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Thermo Fisher Scientific, Inc. (United States), Bio-Rad Laboratories, Inc. (United States) and Ortho-Clinical Diagnostics, Inc. (India).
Analyst at AMA have segmented the market study of Global Troponin Diagnostic Tests market by Type, Application and Region.
On the basis of geography, the market of Troponin Diagnostic Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
In Feb 2021, Psyros Diagnostics announced the development of ultra-sensitive, ultra-fast, point of care diagnostics based on single molecue counting. The company get grant of around Euro 99,400 by NHSEI SBRI Healthcare. Under this ememrgency grants, the company produced a prototype of its troponin diagnostic test system.
Influencing Market Trend
- High sensitivity troponin test kits products
- By application, the global troponin market is driven into acute coronary syndrome, myocardial infarction, which is a leading application of troponin
- Developmental opportunities for Troponin diagnostic kits are majorly in prize of the kit, home testing kits and availability of the kit
- Major restraints for troponin diagnostic kits was observed that 68% of test kits used for the diagnosis of physically injured patients, followed by older people
- Time taking process creates many challenges to lower-sensitivity troponin assays
Key Target AudienceHospitals, Medical Institutes and Pathology Labs
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Frequently Asked Questions (FAQ):
1. At what growth rate would the Troponin Diagnostic Tests market expands?
The Global Troponin Diagnostic Tests market is expected to see a growth of % during projected year 2020 to 2026.
2. Who are the prominent players of the Global Troponin Diagnostic Tests market?
The prominent players of Global Troponin Diagnostic Tests market are Abbott Diagnostics, Inc. (United States.), F. Hoffmann-La Roche Ltd (Switzerland), BioMrieux SA (France), BG Medicine, Inc. (United States), Singulex, Inc. (United States), Alere, Inc. (United States), Siemens Healthcare Diagnostics, Inc. (Germany), Beckman Coulter, Inc. (United States), LifeSign LLC (United States) and Danaher Corporation (United States), to name a few.
3. What are the top priorities to focus for Troponin Diagnostic Tests marketís growth?
In this highly competitive & fast evolving Troponin Diagnostic Tests industry, the top strategic priorities would remain consistent like innovation, R&D and M&A.